Latin America has been under-represented in dementia clinical trials, we must turn the corner
The world’s population is aging, life expectancy is increasing in the past century as result of the improvements in healthcare and the people arrive to live longer and healthier. However, this has also resulted in increase the number of people with age-re lated diseases like most of dementia etiolog...
- Autores:
-
Román, Fabián
Barceló, Ernesto
Allegri, Ricardo Francisco
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2022
- Institución:
- Corporación Universidad de la Costa
- Repositorio:
- REDICUC - Repositorio CUC
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.cuc.edu.co:11323/9721
- Acceso en línea:
- https://hdl.handle.net/11323/9721
https://repositorio.cuc.edu.co/
- Palabra clave:
- Alzheimer
Dementia
Life expectancy
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
| Summary: | The world’s population is aging, life expectancy is increasing in the past century as result of the improvements in healthcare and the people arrive to live longer and healthier. However, this has also resulted in increase the number of people with age-re lated diseases like most of dementia etiologies (fundamentally Alzheimer and Vascular dementia). The growth of people with dementia in the next 20 years will be exponential around the world but even more in those countries with Low and Medium Incomes (LMIC) due to the recently and future improve in health care and quality of life |
|---|